
MOUNTAIN VIEW, California, August 25, 2026, 16:24 EDT — Shares of Intuit fell more than 7% after the company forecast a 9%-10% increase in revenue for 2027, signaling a slowdown in expected growth.
| Metric | Actual | Street | Beat |
|---|---|---|---|
| Revenue | $4.354B | $4.27B | +2.0% |
| Adjusted EPS | $4.03 | $3.58 | +12.6% |
| Online Ecosystem | $2.6B | — | +17% YoY |
| Credit Karma | $743M | — | +16% YoY |
The definition change narrows the apparent EPS miss. The revenue midpoint of $4.304B still trails the $4.35B consensus by about 1.1%.
| Firm / group | Rating | Target | Upside vs close |
|---|---|---|---|
| Jefferies | Buy | $500 | 39.3% |
| Citi | Buy | $457 | 27.3% |
| 35-analyst avg. | Buy | $446.02 | 24.3% |
| TD Cowen | Hold | $328 | −8.6% |
Market snapshot: August 25, 2026, 14:21 EDT · Regular session
The shares remain 82.7% below their $57.42 high. The 13-analyst average target implies 19.2% upside.
Fresh catalyst
NuScale deployed Nuclearn AtomAssist and NPX across engineering and knowledge management.
Proof-of-concept search-time reduction: up to 80%.
No customer contract, order value, revenue or savings target was disclosed.
| Signal | Value | Investor read |
|---|---|---|
| Q2 revenue | $75K | ≈99% below estimate |
| Session value gain | ≈$379M | >5,000× Q2 revenue |
| Liquidity | $1.9B | 44.6% of market cap |
| ATM authorization | Up to $750M | 17.6% of market cap |
| Module output | 77 MWe | Up to 924 MWe for 12 modules |
| Reference | Target |
|---|---|
| Cantor · Buy | $20.00 |
| Texas Capital · Buy | $12.00 |
| RBC · Hold | $10.00 |
| Citi · Sell | $6.50 |
Consensus: 5 Buy, 7 Hold, 1 Sell.
Internal efficiency is not the same as customer revenue. The proof-of-concept result may not translate into lower project costs. Licensing, financing, manufacturing readiness and binding customer commitments remain the larger valuation tests. Sector-wide strength also amplified Tuesday's move: Oklo rose 12.8% and Nano Nuclear Energy gained 6.4% in the same snapshot.
Sources: NuScale Power releases dated August 5 and August 25, 2026; SEC filing dated August 11, 2026; Google Finance market and analyst data captured August 25, 2026, 14:21 EDT. Calculations use displayed figures and may differ because of rounding.
NYSE: RBRK · Fiscal Q2 2027 setup · Market snapshot: August 25, 2026, 14:33 EDT
The chart uses verified closes through Aug. 21 and the Aug. 25 intraday snapshot. The stock remains about 26% above its July 31 close despite Tuesday's drop.
| Metric | Latest / guide | Signal |
|---|---|---|
| Q1 revenue | $387.1M; +39% YoY | Growth |
| Q1 subscription ARR | $1.57B; +32% YoY | Core demand |
| Q1 free cash flow | $73.6M; 19% margin | Leverage |
| Q2 revenue guide | $395M–$397M | +27.7% YoY at midpoint |
| Q2 adjusted EPS guide | $0.03–$0.05 | Profitable |
| FY27 revenue guide | $1.638B–$1.648B | Valuation base |
| FY27 free-cash-flow guide | $293M–$303M | ≈18.1% midpoint margin |
| Firm / sample | Rating | Target | Implied move |
|---|---|---|---|
| Wells Fargo | Overweight | $120 | +31.9% |
| Oppenheimer | Outperform | $120 | +31.9% |
| Cantor Fitzgerald | Overweight | $120 | +31.9% |
| KeyBanc | Overweight | $112 | +23.1% |
| 27-analyst consensus | Strong Buy | $103.07 | +13.3% |
ARR growth below expectations, cautious forward guidance, or heavier investment could compress the revenue multiple. The stock's August rally also raises the threshold for a favorable post-earnings reaction.
Sources: Rubrik investor relations, Yahoo Finance, Wells Fargo research summary, S&P Global analyst compilation and company guidance. Time-sensitive market figures are stamped August 25, 2026, 14:33 EDT.
| Target | Crucial Innovation |
| Sector shift | Apparel → botanical pharma |
| Financing lead | GeoNova Holdings |
| Valuation | Undisclosed |
| Consideration | Undisclosed |
| Analyst ratings | None available |
Critical next disclosure: audited target results, definitive financing terms, share consideration and a closing timetable.
| Six months to Mar. 31 | 2026 | Change / read |
|---|---|---|
| Revenue | $4.43M | −22.5% |
| Gross margin | 4.35% | From 25.9% |
| Net loss | ($9.74M) | Vs. profit |
| Share-based marketing cost | $8.41M | 86% of net loss |
| Cash | $5.13M | At March 31 |
| Operating cash use | $0.55M | Six months |
Sources: Yahoo Finance live U.S. trending table; 707 Cayman company release at 11:20 EDT on August 25, 2026; SEC Form 6-K filed August 10, 2026. Market figures are time-stamped above. The acquisition is not definitive.
Market snapshot: August 25, 2026, 13:12 EDT · U.S. regular session. Partnership announced August 25, 2026.
Commercial terms, minimum usage and contract duration were not disclosed. The value lies in workload access; monetization still requires consumption.
$104B backlog compared with $48.67B equity value. Backlog converts only as capacity becomes available and services are delivered.
| Metric | Q2 2026 | YoY / margin |
|---|---|---|
| Revenue | $2.575B | +112% |
| Adjusted EBITDA | $1.510B | 59% margin |
| Operating loss | $49M | -2% margin |
| Net loss | $626M | -24% margin |
| Interest expense | $640M | 24.9% of revenue |
| Property purchases | $6.422B | 2.49× revenue |
June 30, 2026. Debt is the sum of current and long-term recourse and non-recourse balances.
| Firm / set | Date | Rating | Target | Upside / downside |
|---|---|---|---|---|
| 38-analyst consensus | Aug. 25 | Buy | $144.17 | +63% |
| Truist | Aug. 19 | Buy | $155 | +76% |
| Goldman Sachs | Aug. 20 | Hold | $139 | +58% |
| Barclays | Aug. 13 | Hold | $105 | +19% |
| Bernstein | Aug. 12 | Sell | $74 | -16% |
Rescale adds a distribution layer for compute-heavy engineering. CoreWeave can diversify workload types while reusing the same GPU, networking and storage stack. Revenue growth above 100% and a backlog twice the equity value create substantial operating leverage if utilization rises.
No commercial value was disclosed. Debt is more than six times cash, interest consumed nearly one quarter of quarterly revenue, and property purchases were 2.5 times revenue. Slow deployments or weak utilization can make new demand expensive to serve.
Sources: CoreWeave–Rescale announcement; CoreWeave Q2 results; StockAnalysis market data; analyst consensus. Figures timestamped as shown; calculations by TS2.
DefendAir uses net-based interception rather than explosives or gunfire. The package includes launchers, Net Pods and on-site operator training.
| Customer | U.S. federal security entity |
| Order size | Not disclosed |
| Order contents | Hardware + training |
| Analyst ratings found | 0 |
| Shares outstanding | 25.93M |
Watch: follow-on awards, disclosed order values, delivery timing and recurring Net Pod demand.
| Metric | 2025 | Signal |
|---|---|---|
| Revenue | $1.047M | +12.3% |
| Gross profit | ≈$0.050M | ≈4.8% margin |
| Net loss | ($5.412M) | Improved 51% |
| Cash + short-term deposits | ≈$4.2M | At Dec. 31 |
| 2026 direct offerings | ≈$7.5M gross | Liquidity + dilution |
Sources: ParaZero SEC filing dated August 25, 2026; Google Finance; ParaZero 2025 results and product disclosures. No order value or reliable analyst consensus was available at publication.
GPU-services contract, customer warrant and execution dashboard
Closes: $8.24, $8.10, $8.32, $8.43, $9.05, $9.36; Aug. 25 intraday: $10.48.
Annualized contract value is 6.3× annualized Q3 guidance. Recognition timing is not disclosed.
| Cash and equivalents | $203.3M | June 30 |
| Total liquidity | $220.5M | June 30 |
| Convertible note payable | $358.8M | June 30 |
| Customer warrant | 50.81M | $0.01 strike |
| Warrant / economic shares | 12.7% | Class A+C base |
| Q2 revenue | $40.4M | +61% YoY |
| Northern Data contribution | $10.1M | Post-close period |
| Q2 net loss | -$80.3M | GAAP |
| Adjusted EBITDA | -$16.6M | vs. -$20.5M |
| Existing GPU utilization | ~85% | Q2 |
| Firm | Rating | Target |
|---|---|---|
| Maxim Group Aug. 19 | Buy | $22 |
| Oppenheimer Aug. 17 | Hold | — |
Two tracked analysts; consensus Hold. Coverage is too narrow for a robust distribution.
| Positive | $13.7B anchor order; 85% utilization on the existing GPU estate; a new 52-week stock high. |
| Unresolved | Customer identity, delivery calendar, financing terms, capex budget and revenue recognition. |
| Downside | Near-zero-strike warrant, further equity dilution, added leverage, construction delays and contractual remedies. |
| Trailing revenue | $117.7M |
| Current market cap / sales | 35.6× |
| 2026 revenue consensus | $243.7M |
| 2027 revenue consensus | $559.0M |
| Average target / current | $22 / $10.48 |
Forward figures are analyst estimates, not company guidance.
Sources: RUM Form 8-K; Q2 Form 10-Q; Q2 results; StockAnalysis market data; analyst estimates; Reuters.
| Firm | View | Target | vs $12.88 |
|---|---|---|---|
| Needham | Buy | $21.00 | +63.0% |
| Baird | Buy | $20.00 | +55.3% |
| Rosenblatt | Hold | $13.00 | +0.9% |
| Craig-Hallum | Hold | $13.00 | +0.9% |
| Morgan Stanley | Sell | $12.60 | −2.2% |
Claros closes Navitas's power chain from the grid to the processor package. The transaction adds a claimed $3.5B VPD/IVR market, but management expects the revenue lift mainly from 2028–2029.
Current GaN/HV-SiC SAM $3.5BNew JFET SAM $1.0BClaros VPD/IVR SAM $3.5B+Post-deal 2030 SAM $8B+
NASDAQ: AMD · Stock move · Server CPU thesis
AMD snapshot: August 25, 2026, 12:45 EDT · U.S. regular session · Peer snapshots: 12:50–12:59 EDT
+$19.75 · +4.33%
About $32.2B added today.
Shares by 12:40 EDT.
Execution remains expensive.
Raymond James moved AMD to Strong Buy from Outperform and raised its target from $565. The firm models a 44% five-year CAGR for server CPUs, reaching $201B in 2030.
Fresh catalyst: Aug. 25Target upside: 34.5%Analyst: Simon Leopold| Measure | Q2 2026 | Y/Y |
|---|---|---|
| Revenue | $11.54B | +50% |
| Data Center | $6.72B | +107% |
| Data Center mix | 58% | Core engine |
| Non-GAAP gross margin | 56% | +13 pts |
| Q3 revenue midpoint | $13.0B | ≈+41% |
Analysts model $50.8B revenue and $7.57 adjusted EPS. The target case needs earnings to compound faster than sales.
| Source | Rating | Target | Upside at $476.50 | Date |
|---|---|---|---|---|
| Raymond James | Strong Buy | $641 | 34.5% | Aug. 25 |
| Roth MKM | Buy | $650 | 36.4% | Aug. 20 |
| BMO Capital | Buy | $550 | 15.4% | Aug. 20 |
| Bernstein | Buy | $650 | 36.4% | Aug. 13 |
| 54-analyst consensus | Strong Buy | $612.29 | 28.5% | Aug. 25 snapshot |
| Company | Price | Session move | Market cap | Forward P/E |
|---|---|---|---|---|
| AMD | $476.50 | +4.33% | $779B | 41.1× |
| Nvidia | $212.34 | +1.85% | $5.14T | 20.8× |
| Intel | $88.21 | +1.09% | $463.5B | 52.5× |
AMD's outperformance isolates the company-specific upgrade from the broader chip rebound.
A slower agentic-AI rollout, weaker server share gains, export controls or price competition would challenge the $201B thesis. Nvidia reports August 26 after the close. Its outlook can reset the entire AI-infrastructure valuation curve.
Sources: AMD market data, S&P Global analyst consensus, AMD Q2 results, AMD EPYC specifications, Raymond James upgrade coverage, Nvidia data and Intel data. Time-sensitive figures are stamped August 25, 2026, 12:40–12:59 EDT.
The board authorized purchases of Class B stock through Aug. 21, 2027. No minimum purchase is required. The board may modify, pause or end the program without notice.
| Firm | Action | Rating | Target | Date | Vs. $1.89 |
|---|---|---|---|---|---|
| Freedom Broker | Upgrade | Hold | $2 | Aug. 16, 2026 | +5.8% |
| H.C. Wainwright | Reiterate | Buy | $6 | Feb. 2, 2026 | +217.5% |
Coverage is sparse. The target spread highlights unusually wide uncertainty around commercialization and valuation.
Market snapshot: August 25, 2026, 11:31 EDT · U.S. regular session
Up 8.63% from a $35.17 prior close.
About $1.96B added during the move.
Shares traded by 11:31 EDT on August 25.
Versus 22.68× for Dell and 21.50× for Cisco.
The $68.5 billion midpoint implies 75.4% growth. Cisco’s October availability is a channel catalyst; no order value has been disclosed.
Consensus: Hold · Average target $42.38 · Implied upside 10.9% from $38.21.
| Company | Price | Daily move | Market value | Forward P/E |
|---|---|---|---|---|
| Super Micro Computer (NASDAQ: SMCI) | $38.21 | +8.63% | $24.71B | 8.81× |
| Dell Technologies (NYSE: DELL) | $453.27 | +4.64% | $292.88B | 22.68× |
| Cisco Systems (NASDAQ: CSCO) | $110.97 | +0.67% | $437.38B | 21.50× |
Prices and valuation metrics: StockAnalysis snapshots at 11:30–11:31 EDT, August 25, 2026. SMCI outperformed the equal-weight daily move of Dell and Cisco by about 6.0 percentage points.
Cisco supplies distribution and enterprise validation. Supermicro supplies dense rack-scale compute and liquid cooling. The commercial link is direct, but not yet quantified: an October product path can widen customer access, while revenue depends on orders, pricing, delivery and margin.
| Q4 FY2026 sales | $11.1B | +93.2% YoY |
| Q4 FY2026 gross margin | 17.5% | +8.0 points YoY |
| Q1 FY2027 sales guide | $14.5–$15.5B | Midpoint +34.9% vs. Q4 |
| FY2027 sales guide | $65–$72B | +66.4% to +84.3% |
Cisco disclosed no committed orders, pricing or margin. Taiwan’s August 24 server-export case adds compliance scrutiny: prosecutors allege 74 of 130 B300 systems reached China through indirect routes, while customs stopped 56. Supermicro says it is not an investigation target and is not accused of wrongdoing.
Sources: Cisco, Supermicro results, Reuters, StockAnalysis market data and analyst consensus. Time-sensitive market figures are stamped August 25, 2026, 11:30–11:31 EDT.
Factory expansion is being financed with a third large ATM program.
*Illustrative full $600M sale at $112.85. The company controls timing and amount; actual issuance can differ.
| Program | Authorized | Shares sold through June | Net proceeds |
|---|---|---|---|
| First | $500M | 4.83M | $490.0M |
| Second | $600M | 2.95M | $538.8M |
| August | $600M | Not disclosed | Not disclosed |
| Total | $1.70B | 7.78M+ | $1.03B+ |
Six months ended June 30, 2026. *Cash, cash equivalents and restricted cash.
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $191.9M | $103.0M | +86.4% |
| Gross profit | $53.2M | $31.2M | +70.7% |
| GAAP gross margin | 27.7% | 30.3% | −2.6 pts |
| GAAP net loss | −$22.8M | −$9.1M | Loss widened |
| Non-GAAP EPS | $0.06 | −$0.16 | Turned positive |
| Guidance | Low | High | Sequential read |
|---|---|---|---|
| Revenue | $255M | $290M | +33% to +51% |
| Non-GAAP gross margin | 29.0% | 30.5% | Above Q2 GAAP margin |
| Non-GAAP net income | $10.1M | $24.0M | Profit ramp |
| Non-GAAP EPS | $0.11 | $0.26 | 92.8M assumed shares |
| Analyst | Firm | Rating | Target | Target vs $112.85 |
|---|---|---|---|---|
| Michael Genovese | Rosenblatt | Buy | $220 | +94.9% |
| Ryan Koontz | Needham | Buy | $190 | +68.4% |
| Simon Leopold | Raymond James | Buy | $178 | +57.7% |
| Tim Savageaux | Northland | Hold | $120 | +6.3% |
| Dave Kang | B. Riley | Hold | $109 | −3.4% |
Six-analyst consensus: Buy. Average target: $163.40, or 44.8% above the 11:06 EDT quote.
ATM sale pace800G output1.6T rampGross marginCustomer concentration
Added capacity converts strong demand into revenue faster than share issuance expands the base.
Ramp costs, deployment delays or lower selling prices weaken returns on newly raised capital.
Rezolve AI’s first major distributed-database deployment passed Google’s technical review. The market added about $209 million in equity value before either side disclosed contract revenue.
Technical scope: detailed. Contract economics: absent.
| Measure | Period | Reading |
|---|---|---|
| Revenue | FY 2025 | $46.8M audited |
| Gross margin | FY 2025 | 66% audited |
| Net loss | FY 2025 | $(101.4)M |
| Operating cash flow | FY 2025 | $(63.1)M |
| Cash | Dec. 31, 2025 | $111.1M |
| Revenue | H1 2026 | ≈$127M preliminary |
| Revenue guidance | FY 2026 | ≈$360M |
The gain equals roughly 4.5× audited FY 2025 revenue. It does not represent disclosed contract revenue.
Consensus collected August 25, 2026; underlying ratings span the prior 12 months.
What is the contract value? When does revenue recognition begin? Which costs support the deployment? Can the platform expand beyond 10 networks without lowering margins?
No fees, minimum commitment or revenue timing disclosed.
Preliminary H1 revenue remains unaudited until the September release.
The 2025 Form 20-F reported losses, cash burn and a going-concern warning.
The M6 Mac mini raises the entry price 12.5%. The investor question is whether constrained local-AI demand protects margin without choking unit growth.
Quarter ended June 27; USD billions
Both new starting prices are $100 above the latest M4 generation. The base percentage increase is twice the Pro increase.
Performance figures are Apple claims versus M4; real workloads may differ.
| Signal | Bull case | Bear case | Next evidence |
|---|---|---|---|
| Delivery times | Long waits confirm AI demand | Lost shipments cap sales | September 22 availability |
| Mac growth | 29% momentum persists | Launch pull-forward fades | Fiscal Q4 category sales |
| Pricing | $100 protects gross profit | 12.5% entry hike hurts units | Retail discounts and mix |
| Valuation | AI hardware earns premium | 35.6× P/E limits upside | Guidance and estimate revisions |
Sources: Apple fiscal Q3 release and SEC Form 10-Q; Google Finance; The Verge; 9to5Mac; Fortune. Market data captured August 25, 2026, 09:27 EDT. Product performance figures are manufacturer claims. Calculations may not sum due to rounding.
Investors expect near-doubling sales and a clean Rubin handoff, yet options price a smaller move than Nvidia's recent earnings history.
The market prices 2.0 percentage points less movement than Nvidia's 12-quarter average. That is the core asymmetry: expectations are demanding, but hedging is comparatively cheap.
| Metric | Verified level |
|---|---|
| Q1 FY2027 revenue | $81.6bn · +85% y/y |
| Q1 data-center revenue | $75.2bn · +92% y/y |
| Q2 company guidance | $91.0bn ±2% |
| Q2 analyst consensus | $92.18bn · nearly +100% y/y |
| Q3 analyst consensus | $104.20bn · +82.8% y/y |
| Q2/Q3 adjusted margin | About 75% |
Consensus sits only $1.18bn, or 1.3%, above the midpoint of Nvidia's Q2 guide. The larger test is Q3: Rubin must add growth without denting margin.
Consensus: 59 Buy · 2 Hold · 1 Sell · average target $304.73.
Published recommendations dated 18–21 Aug 2026. The average target implies 46.2% upside from the 24 Aug close; targets are not forecasts of the next-session move.
Revenue clears $92.18bn, gross margin holds near 75%, and management confirms a smooth autumn Rubin ramp. Morgan Stanley estimates Rubin could supply nearly $9bn of Q3 sales.
Results land near consensus and Q3 guidance supports $104.20bn. A move inside $197.14–$219.64 would broadly match the options market's priced range.
Rubin timing slips, margin drops, or customer-financing exposure expands. Nvidia-linked platforms target more than $500bn of financing, while one OpenAI lease guarantee can reach $105bn.
Year to 24 Aug 2026 close. Nvidia trails the semiconductor index by 49.3 percentage points.
| Premarket snapshot | 25 Aug · 07:50 EDT |
| Fiscal Q2 report | 26 Aug · after US close |
| Rubin shipments | Expected autumn 2026 |
| China assumption | No data-center compute revenue in Q2 guide |
Updated 25 August 2026, 20:45 AEST · ASX cash market closed · Data are notifications and may be revised
| Jurisdiction | Cases to 10 Aug | Share |
|---|---|---|
| Northern Territory | 274 | 53.4% |
| Western Australia | 217 | 42.3% |
| South Australia | 17 | 3.3% |
| Queensland | 5 | 1.0% |
| 22 May | Incident declared nationally significant; more than 230 cases. |
|---|---|
| 10 Aug | 513 cases; 28 notifications in prior fortnight, down from 35. |
| 25 Aug | 538 cases; response package raised to A$13m. |
| Next | Fortnightly CDC reports; booster uptake; remote-housing delivery. |
| Scenario | Signal | Market implication |
|---|---|---|
| Base | Fortnightly cases keep declining; testing stable | Surge spending plateaus; logistics pressure eases |
| Upside | Booster uptake rises; no new geographic spread | Lower health-system utilization and procurement urgency |
| Downside | Testing reveals hidden spread or housing delays persist | Longer staffing, transport and treatment commitments |
The A$13m package is tactical. The A$4bn remote-housing commitment is structural and about 308 times larger. Execution, not headline vaccination coverage, is the key long-duration variable.
Risk: Recent declines may be overstated because testing and notification lag. Hospitalisation also reflects infection-control practice, not disease severity alone.
*A$13m divided by 538 notifications; this is not a treatment-cost estimate. Sources: Australian CDC epidemiological update dated 10 August 2026; Australian CDC disease page; ABC News report updated 25 August 2026 at 11:23 AEST; Australian Government remote-housing announcement; ASX cash-market hours. Scenario labels are analytical, not government forecasts.
| Edition | Price |
|---|---|
| Standard | $79.99 |
| Ultimate | $99.99 |
| Upgrade | +$20 / +25% |
| Metric | Reading |
|---|---|
| Q1 FY27 net bookings | $1.39bn · −3% YoY |
| Q1 GAAP revenue | $1.53bn |
| Q1 GAAP net result | −$34.1m |
| Recurrent share of bookings | 84% |
| FY27 GAAP revenue outlook | $7.9–8.1bn |
| FY27 operating cash flow | >$1.0bn |
| Firm · date | View | Target |
|---|---|---|
| JPMorgan · Aug 11 | Overweight | $310 |
| Roth · Aug 10 | Buy | $300 |
| Wells Fargo · Aug 10 | Overweight | $300 |
| Oppenheimer · Aug 10 | Outperform | $280 |
| BTIG · Aug 10 | Buy | $313 |
High preview engagement converts into stronger pre-orders and an above-plan Ultimate mix. A 10m-edition upgrade scenario adds $200m of gross consumer spending.
The preview stabilizes marketing control. Fiscal 2027 bookings remain near the $8.1bn midpoint and the November 19 launch holds.
Technical criticism, weak premium mix or another delay narrows the valuation gap. Muted engagement after Aug. 27 is the first observable warning.
Quarter ended 30 Jun 2026. Company-adjusted measures.
Reported revenue grew faster than ticket count. Using the rounded growth rates, implied revenue per ticket increased about 6.5%.
Revenue-per-ticket is a calculated intensity measure, not a disclosed consumer fee.
| Firm | Date | Action | Target | Upside vs $184.59 |
|---|---|---|---|---|
| Citigroup | 3 Aug 2026 | Buy maintained | $212 | 14.8% |
| Guggenheim | 31 Jul 2026 | Buy maintained | $218 | 18.1% |
| Oppenheimer | 31 Jul 2026 | Outperform maintained | $210 | 13.8% |
| Susquehanna | 31 Jul 2026 | Hold maintained | $187 | 1.3% |
Balance sheet: 30 Jun 2026. Market/valuation metrics checked 25 Aug; earnings multiples are distorted by legal and non-cash items.
| Exposure | Equity | 24 Aug close | Market value |
|---|---|---|---|
| Integrated promoter + ticketing | LYV | $184.59 | ≈$43bn |
| Immersive venue/media | SPHR | $157.31 | $5.65bn |
| Secondary marketplace | SEAT | $7.00 | $78.7m |
Different business models show Live Nation’s scale advantage; they are not direct valuation comparables.
Watch execution, complaints and any disclosed cancellation scale.
The judge has not ruled on Live Nation’s bid for judgment or a new trial.
Track whether revenue continues to outpace ticket volume.
Call of Duty's free weekend is the next live check on whether Microsoft can reverse falling Xbox content revenue before the October launch.
| Edition | Steam price |
|---|---|
| Standard | $69.99 |
| Vault | $99.99 |
| Premium | +$30 / +42.9% |
| Firm | Rating | Target |
|---|---|---|
| Wells Fargo · Aug. 12 | Overweight | $700 |
| Bernstein · Aug. 10 | Outperform | $660 |
| Tigress · Aug. 5 | Buy | $690 |
| Stifel · Jul. 30 | Hold | $450 |
| Market capitalization | ≈$3.62tn |
| Trailing P/E | ≈27.1× |
| Forward P/E | ≈24.5× |
| FY2026 revenue | $331.8bn |
| FY2026 EPS | $17.95 |
Modern Warfare 4 is important to Xbox's holiday content mix. Microsoft, however, earns most of its valuation from cloud and enterprise software. A beta surprise must be large enough to change gaming estimates before it can compete with Azure as a stock driver.
CATALYST: OPEN BETARISK: MIXED REVIEWSLAUNCH: OCT 23
NASDAQ: AAOI · Company dashboard
Market snapshot: August 24, 2026, 18:44 EDT. Regular-session prices are official 16:00 EDT closes; after-hours figures are separately labelled. Fundamentals use the latest reported quarter or trailing period.
Cash close
$107.63
Aug. 24, 16:00 EDT
Daily move
−13.77%
−$17.19 per share
After hours
$108.18
+0.51%, 18:44 EDT
Volume
14.99M
Aug. 24 cash session
Market cap
$9.14B
At Aug. 24 close
Forward P/E
46.8×
S&P Global snapshot
Regular-session closes, August 17–24, 2026. The final gap followed the August 21 ATM filing.
| Revenue, Q2 2026 | $191.9M | +86% YoY |
| GAAP net income, Q2 | −$22.8M | Loss |
| Adjusted net income, Q2 | $5.5M | Positive |
| Cash + restricted cash, Jun. 30 | $508.8M | Reported |
| Revenue, trailing 12 months | $596.0M | Aug. 24 snapshot |
| Net income, trailing 12 months | −$57.0M | Loss |
Company Q3 guidance was issued August 6, 2026. Full-year revenue and free-cash-flow estimates were last updated August 19, 2026.
| Company | Close | Day | Forward P/E | Market cap |
|---|---|---|---|---|
| AAOI | $107.63 | −13.77% | 46.8× | $9.14B |
| LITE | $830.17 | −4.22% | 38.4× | $74.47B |
| COHR | $275.49 | −4.85% | 29.3× | $53.95B |
| GLW | $145.55 | −2.86% | 40.5× | $125.38B |
AAOI underperformed the three-peer average decline of 3.98% by 9.79 percentage points.
| Firm | View | Target |
|---|---|---|
| Rosenblatt | Buy | $220 |
| Needham | Buy | $190 |
| Raymond James | Outperform | $178 |
| Northland | Market Perform | $120 |
| B. Riley | Neutral | $109 |
Six-analyst consensus: Buy. Average target: $163.40, or 51.8% above the August 24 close. The listed calls date from August 7–19.
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A large surprise can reset expectations for household spending and near-term growth, with read-through to Treasuries, USD and cyclical stocks.
Housing remains highly rate-sensitive; the print can move homebuilders, mortgage-sensitive names and the long end of the Treasury curve.
Guidance can influence software multiples and sentiment around U.S. small-business activity.